• Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor:
  An in silico analysis 10.11.2026

• Coronavirus (SARS-CoV-2) in gastroenterology and its current epidemiological situation:
  An updated review until January 2021 10.11.2026

• Current coronavirus (SARS-CoV-2) epidemiological, diagnostic and therapeutic approaches:
  An updated review until June 2020 10.11.2026

• Seroprevalence of SARS-CoV-2 antibodies in low-income university students 10.11.2026

• What about incorporating selenium in the therapeutic regimen of SARS-CoV-2? 10.11.2026

• Association of sleep quality before and after SARS-CoV-2 infection with clinical outcomes in hospitalized patients with COVID-19 in China 10.11.2026

• Mutations in the SARS-CoV-2 spike protein modulate the virus affinity to the human ACE2 receptor, an in silico analysis 10.11.2026

• Potential role of Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) in SARS-CoV-2 infection:
  First insights 10.11.2026

• Is there a bidirectional interaction between periodontitis and the severity of SARS-CoV-2 infection? 10.11.2026

• Elevated risk of thrombotic manifestations of SARS-CoV-2 infection in cancer patients 10.11.2026

• Analyzing the interaction of human ACE2 and RBD of spike protein of SARS-CoV-2 in perspective of Omicron variant 10.11.2026

• Delayed skin reactions and mRNA vaccines against SARS-CoV-2 10.11.2026

• Seroprevalence of SARS-CoV-2 antibodies in radio and television workers 10.11.2026

• Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV 10.11.2026

• Delayed skin reactions after the second dose of mRNA vaccines against SARS-CoV-2 10.11.2026

• Comparison of cycle-threshold-values between two commercial SARS-CoV-2 PCR assays 10.11.2026

• Genomic evolution of the SARS-CoV-2 Variants of Concern 10.11.2026

• Post‐Acute Sequelae of SARS‐CoV‐2 and Osteoarthritis Progression:
  Inflammatory and Immunologic Mechanisms 10.11.2026

• A randomized controlled trial of an intravenous SARS-CoV-2 protease inhibitor PF-07304814 for hospitalized COVID-19 patients 10.11.2026

• A dual-function adenoviral system for transgene delivery and gene editing for host factor studies in a murine model of SARS-CoV-2 infection 10.11.2026

• SARS-CoV-2 Lineage Distribution and Genome Sequence Quality in Zimbabwe, November 2022 to January 2024 10.11.2026

• Detection of SARS‐CoV‐2 in Semen Months After COVID‐19:
  Potential Evidence of Low‐Level Replicative Persistence 10.11.2026

• Prenatal SARS‐CoV‐2 infection, COVID‐19 vaccination, and preschool neurodevelopment:
  A confounder‐adjusted cohort study 10.11.2026

• Surface-Enhanced Raman Spectroscopy (SERS) of SARS-CoV-2 Spike (S-) Protein Variants 10.11.2026

• Variable Continental Transmission Patterns Drive Disparate SARS-CoV-2 Lineage Emergence in Bolivia and Peru 10.11.2026

• Effectiveness of the 2025-2026 Covid-19 vaccine against Covid-19-associated emergency department visits and hospitalizations among U.S. veterans:
  An observational study. 09.11.2026

• SARS-CoV-2 variants and cardiovascular complications - Implications for surveillance and vaccination:
  A narrative review. 09.11.2026

• Evaluating City-Cut Geographic Risk Classification for a Pandemic Travel-Record System in Shanghai, China:
  Retrospective Observational Analysis. 09.11.2026

• Retraction:
  Epitope-based peptide vaccine design and elucidation of novel compounds against 3C like protein of SARS-CoV-2. 09.11.2026

• An active national survey of the BNT162b2 mRNA COVID-19 vaccine safety in Israeli children. 09.11.2026

• Vitamin D status and COVID-19 severity and outcomes:
  an observational cohort study. 09.11.2026

• Multimodal LFIA platform integrating visual readout, smartphone grayscale imaging and surface-enhanced Raman scattering for point-of-care detection of SARS-CoV-2 protein. 09.11.2026

• Adaptive Workforce Strategies in Public Health Emergencies:
  A Quasi-Experimental Study with a Historical Control Group. 09.11.2026

• Retraction:
  Epitope-based peptide vaccine design and elucidation of novel compounds against 3C like protein of SARS-CoV-2 09.11.2026

• Computational Design and In Silico Immune Profiling of a Broad-Coverage Circular mRNA Vaccine Candidate against SARS-CoV-2 09.11.2026

• Antibody-Driven Enrichment and Immunological Profiling of Phage-Displayed Peptide Populations from a SARS-CoV-2 Convalescent IgG Selection 09.11.2026

• Activation of IgG antibody and mucosal T cell responses to MERS-CoV in human nasopharynx-associated lymphoid tissue by a ChAdOx1 vectored vaccine candidate and inactivated MERS-CoV 09.11.2026

• From Attraction to Repulsion:
  Omicron-Driven Rewiring of Nanobody Interfaces on the SARS-CoV-2 RBD 09.11.2026

• COVID-19 vaccination and patient-reported health one year after SARS-CoV-2 infection 09.11.2026

• AI-Supported Semiquantitative CT Characterization of COVID-19 Pneumonia Across SARS-CoV-2 Wild-Type, Alpha, and Delta Variants and Its Association with Clinical Parameters 09.11.2026

• Figure 7 from:
  Savatenalinton S (2026) A new species of Dolerocypris (Crustacea, Ostracoda) from Thailand, with notes on the taxonomic position of D. marina Hartmann, 1965. ZooKeys 1297:
  59-76. https://doi.org/10.3897/zookeys.1297.216314 09.11.2026

• Figure 8 from:
  Savatenalinton S (2026) A new species of Dolerocypris (Crustacea, Ostracoda) from Thailand, with notes on the taxonomic position of D. marina Hartmann, 1965. ZooKeys 1297:
  59-76. https://doi.org/10.3897/zookeys.1297.216314 09.11.2026

• Design Trade-Offs between Target Binding and Self-Association Revealed by De Novo SARS-CoV2 Binders 09.11.2026

• Deep Learning-Based Prediction of SARS-CoV-2 Spike Antibody Domain Specificity with Sequence Logo Analysis 09.11.2026

• Mutation Hotspot Analysis of SARS-CoV-2 Spike Protein Using Machine Learning and Deep Learning Approaches 09.11.2026

• Discovery of Semicarbazone and Thiosemicarbazone Analogs as Competitive SARS-CoV-2 Virus Main Protease (Mpro) Inhibitors 09.11.2026

• Correction:
  Stillwell et al. West African Clade C MERS-CoV Strains BF785 and Mor213 Induce More Robust Interferon and Inflammatory Signaling Compared to Clade A in Human Respiratory Cells. Viruses 2026, 18, 935 09.11.2026

• The Problem of SARS-CoV-2 Resistance to Antiviral Drugs (Review and Own Experience) 09.11.2026

• Long COVID:
  A Modified Delphi Consensus on Definition, Burden, Diagnosis and Management in Southeast Asia. 07.11.2026

• Structural dynamics and energetic basis of conserved ACE2 binding across SARS-CoV-2 variants. 06.11.2026

• Protein kinase C is a promising host target for anticoronaviral therapy in vitro and in vivo. 06.11.2026

• The magnitude and durability of immune response to the SARS-CoV-2 vaccination among children. 06.11.2026

• Humoral immunity after mRNA SARS-CoV-2 XFG vaccination. 05.11.2026

• SARS-CoV-2 Nsp2 reprograms host immunity to drive pathogenic inflammation. 05.11.2026

• Introducing SARS-CoV-2 wastewater surveillance in Lebanon. 04.11.2026

• Randomised controlled phase I trial of a SARS-CoV-2 monoclonal antibody. 04.11.2026

• Environmental circulation of airborne SARS-CoV-2 particles in intensive care rooms 04.11.2026

• Generation of a fully infectious SARS-CoV-2 encoding an internally tagged nsp3. 02.11.2026

• Is SARS-CoV-2 Infection (COVID-19) Associated With Congenital Anomalies? A Population Study of Congenital Anomaly Surveillance Data and Maternal SARS-CoV-2 Infection in Wales. 01.11.2026

• Deconvolving SARS-CoV-2 mRNA Vaccine Impact on Immunotherapy-Related Survival. 01.11.2026

• SARS-CoV-2 exposure in deer increases with use of human-modified habitat. 01.11.2026

• Population attributable mortality associated with respiratory viruses in Ontario, Canada:
  a population-based ecological analysis. 31.10.2026

• Global burden of type 2 diabetes attributable to SARS-CoV-2 infection 31.10.2026

• Impact of primary series vaccination on clinical presentations and outcomes among critically ill patients with coronavirus disease 2019 (COVID-19) in Taiwan during the Omicron era. 30.10.2026

• Prevalence of antigens and antibodies against SARS-CoV-2 in people deprived of liberty. 30.10.2026

• Estimating SARS-CoV-2 reinfection frequency and infection incidence:
  A modeling study. 29.10.2026

• Effects of leritrelvir for adults with mild-to-moderate coronavirus disease 2019:
  a multicenter real-world study. 27.10.2026

• Simultaneous detection of influenza and SARS-CoV-2 on an AI-nanopore multiplex platform. 27.10.2026

• SARS-CoV-2 ORF6 protein targets IFP35 to inhibit the IFNγ signaling pathway. 26.10.2026

• Polymorphism of amyloid fibrils of a SARS-CoV-2 peptide associated with hemagglutination. 26.10.2026

• Evaluation of whole genome sequencing protocols and target-capture panels for detection of respiratory viruses in clinical specimens. 23.10.2026

• Age-dependent differences in SARS-CoV-2 entry-factor expression and innate immune responses between pediatric and adult liver organoids. 23.10.2026

• Integrated mechanistic and serological analyses reveal determinants of antibody-dependent enhancement in respiratory coronaviruses. 23.10.2026

• MULTIVALENT ACE2 ENGAGEMENT ACTIVATES PIEZO1-SPHINGOMYELINASE SIGNALING IN SARS-COV-2 SPIKE-MEDIATED CELL-CELL FUSION. 23.10.2026

• Serum proteomic profiling identifies transforming growth factor β receptor as a marker of persistent symptoms up to 18 months after mild SARS-CoV-2 infection. 22.10.2026

• Persistently activated virus-specific CD8 T cells indicate antigen-driven immune aberrations in long COVID. 22.10.2026

• The pan-African natural products library compounds oleanolic acid, poinsettifolin B, and rhuschalcone III disrupt SARS-CoV-2 spike-host ACE2 interactions and SARS-CoV-2 replication. 21.10.2026

• Fitting and Selection of Within-Host Models for SARS-CoV-2 Infection 20.10.2026

• Deep untargeted wastewater metagenomic sequencing from sewersheds across the United States. 19.10.2026

• Interactions between respiratory viruses in US adults and children:
  a prospective cohort study. 19.10.2026

• Common viral infections seed regionally distinct resident memory T cells in the human CNS. 18.10.2026

• The SARS-CoV-2 spike receptor-binding domain has evolved decreased inherent antigenicity in humans. 16.10.2026

• Clonotype specificity distinguishes epitope-tailored and permissive somatic hypermutation. 16.10.2026

• The Water-Soluble [60]Fullerene Derivatives as Binders of SARS-CoV‑2 Proteins 16.10.2026

• Evolution of SARS-CoV-2 reshapes upper airway immunity in children 16.10.2026

• A mosaic RBD-nanoparticle pan-sarbecovirus vaccine elicits nanobodies that target highly conserved epitopes. 15.10.2026

• Iron Status in Patients with SARS-CoV-2 Infection. 15.10.2026

• Real-time wearable detection of respiratory infections in pediatric transplant households. 12.10.2026

• High-throughput variant libraries and machine learning enable robust target-site selection for toehold-switch design in Detectrons. 12.10.2026

• SARS-CoV-2 seeds IAPP aggregation and β-cell failure. 09.10.2026

• The impact of COVID-19 restrictions on eating habits, physical activity and mental health in undergraduate students of the Western Cape, South Africa. 08.10.2026

• Transcriptional responses of white-tailed deer to SARS-CoV-2 challenge 07.10.2026

• Social inequalities in SARS-CoV-2 infection in France:
  An intersectional analysis 01.10.2026

• Influenza A (H1N1) and SARS-CoV-2 Transmission in Airplanes:
  Quanta Profiles and Infection Control. 01.10.2026

• Divergent systemic and airway mucosal adaptive immunity to SARS-CoV-2 in African adults 29.09.2026

• The other immune landscape of SARS-CoV-2 evolution. 28.09.2026

• Localized SARS-CoV-2 Infection Triggers a Tissue-Wide Antiviral Response and Functional Impairment of Olfactory Sensory Neurons. 21.09.2026

• Epistasis and the changing fitness landscapes of SARS-CoV-2. 17.09.2026

• Role of Ion Channels in the Pathophysiology of SARS-CoV-2. 16.09.2026

• Healthy vaccinee effect in SARS-CoV-2 vaccinees without documented infection 11.09.2026

Quellen: PubMed, Europe PMC & CrossRef